CRNX
CRNX
NASDAQ · Pharmaceuticals

Crinetics Pharmaceuticals In

$35.38
-0.49 (-1.37%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +39.6% upside
Low Target $38.77
Average Target $49.40
High Target $74.88
Current Price $35.38
Current
$35.38
Target
$49.40
$38.77 $49.40 avg $74.88
Scenario Analysis
Bear Case
$38.77
9.6%
Low target
Base Case
$49.40
+39.6%
Avg target
Bull Case
$74.88
+111.6%
High target
Risk/Reward
11.7x
Highly favorable
Price in Context
52-Week High
$57.99
-39.0% from high
52-Week Low
$25.83
+37.0% from low
50-Day SMA
$49.40
-28.4% vs SMA
200-Day SMA
$38.81
-8.8% vs SMA
RSI (14)
27.9
Oversold
Target vs 52W High
$49.40
-14.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%